This Small-Cap Stock Is Betting Big On AI Healthcare, Posts 47% QoQ Profit Growth; Should You Invest?

Lord's Mark Industries Ltd is in focus after reporting a 47% quarter-on-quarter rise in consolidated net profit for Q2 FY27, while its first-half revenue has already crossed its entire FY26 revenue. The company is also preparing to take its AI-based dialysis machines to overseas markets, with export shipments expected to begin by the end of December 2026.

Lord's Mark Industries Share Price Today

Lord's Mark Industries shares were trading at Rs 76.99, down Rs 0.43 or 0.56% from the previous close of Rs 77.42. The stock opened at Rs 74.55 and touched an intraday high of Rs 78.00 and a low of Rs 74.06.

The stock has a 52-week high of Rs 99 and a 52-week low of Rs 60. Its upper price band stands at Rs 81.29, while the lower price band is Rs 73.55, under the applicable 5% price band.

Lord s Mark Industries

The company is expanding its medical devices and diagnostics business, with AI-powered dialysis machines, cancer screening equipment and other healthcare products forming part of its growth strategy. It has also outlined plans to enter additional international markets and launch new products in 2027.

Lord's Mark Industries Q2 Results: Net Profit Rises 47% QoQ

Lord's Mark Industries reported consolidated revenue from operations of Rs 411.09 crore and net profit of Rs 48.83 crore for the September 2026 quarter. Revenue increased 34% from the preceding quarter, while profit after tax rose 47% quarter-on-quarter.

For the six months ended September 30, 2026, consolidated revenue from operations stood at Rs 718.77 crore. This was already higher than the Rs 684.75 crore reported for the entire FY26.

The company reported first-half EBITDA of Rs 131.51 crore and profit after tax (PAT) of Rs 82.01 crore. Its first-half profit was around 1.7 times the Rs 48.59 crore it earned during the whole of FY26. The consolidated EBITDA margin stood at 18.30%, while the PAT margin was 11.41%.

The company submitted revised unaudited results after identifying typographical errors in its earlier filing, which had included half-year figures where independent second-quarter figures were required. The revised results were reviewed by the Audit Committee and approved by the board on November 14, 2026.

Alongside its financial performance, Lord's Mark Industries is preparing to commercialise its AI-based dialysis machines. Production has started at its Bengaluru facility, and trials began in November at specialised healthcare centres and with Indian customers.

The company has secured export orders for the machines, with commercial shipments to markets including the UK, the US, Africa, Nepal and Bangladesh expected to begin by the end of December 2026. The machines are in the final stage of testing, according to the company's update.

The start of exports is an important milestone to watch as Lord's Mark Industries seeks to expand its medical device business beyond India. However, the actual revenue contribution will depend on the commencement of shipments, order execution and customer demand.

It is also preparing to launch a breast cancer screening device for mass screening in January 2027. The company said the product has received the required regulatory approvals. A sickle cell screening solution is also in the pipeline, with its commercial launch dependent on a manufacturing licence expected in January 2027.

From February 2027, the company plans to introduce a range of AI-based medical devices for doctors and general practitioners in international markets.

"It is necessary to pay attention to shipping numbers, clearance by regulatory agencies, follow-up orders, production capacity utilization and the effect of the revenues from such products on the bottom line. In light of the small-cap status of Lord's Mark Industries, valuation should not be overlooked," said Siddharth Maurya, Founder & Managing Director, Vibhavangal Anukulakara Pvt. Ltd.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+